NCT04243642

PJ-011726 IntelliSpace Cognition MCI Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 117 (actual)
• Sponsor: Philips Electronics Nederland B.V. acting through Philips CTO organization · Industry
• Sex: All
• Age: 50 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study aims to create a reference database of digital cognitive assessment data in combination with neuroimaging data of patients with mild cognitive impairment. The investigators will explore and derive correlations between parameters from routine MRI images and brain volumetric analysis and the digital cognitive data to identify parameters that are relevant to classify MCI patients vs preexisting healthy control data.

Conditions

• MCI
• Cognitive Function 1, Social

Interventions

Type	Name	Description
DEVICE	IntelliSpace Cognition	Philips IntelliSpace Cognition (ISC) is a digital assessment platform that supports Healthcare Professionals (HCP) in assessing the cognition of individuals. It consists of two interfaces connected to the DCDx-module in the cloud. ISC is hosted on the Philips Health Suite Digital Platform (HSDP). The first interface is the patient's interface and is presented via a tablet to collect data on how the patient performs a series of tests. The second interface is the clinician's interface and can be used on any PC or tablet. It allows for assessments to be selected and administered, observations made, data analytics performed and the generation of a report.

Timeline

• Start date: 2020-01-30
• Primary completion: 2022-04-14
• Completion: 2022-04-14
• First posted: 2020-01-28
• Last updated: 2022-07-18

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study